Generated by DeepSeek V3.2| Hypertension (journal) | |
|---|---|
| Title | Hypertension |
| Discipline | Cardiology, Vascular medicine, Physiology |
| Editor | Anna F. Dominiczak |
| Publisher | American Heart Association |
| Country | United States |
| History | 1979–present |
| Frequency | Monthly |
| Openaccess | Hybrid |
| Impact | 9.897 |
| Impact-year | 2022 |
| ISSN | 0194-911X |
| EISSN | 1524-4563 |
| OCLC | 04964071 |
| Website | https://www.ahajournals.org/journal/hyp |
Hypertension (journal). A premier peer-reviewed medical journal dedicated to advancing the understanding of high blood pressure and related cardiovascular disorders. Published monthly by the American Heart Association, it serves as a critical forum for original research on the basic science, clinical management, and population health aspects of hypertension. The journal is recognized globally for its high-impact studies that influence clinical guidelines and therapeutic strategies.
The journal was established in 1979, emerging during a period of significant advancement in cardiovascular research led by institutions like the National Institutes of Health and the Framingham Heart Study. Its founding was championed by key figures in the field, including Dr. Harriet P. Dustan, who served as its first editor-in-chief. The creation of the publication coincided with major scientific meetings such as those of the American Society of Hypertension and the International Society of Hypertension, providing a dedicated platform for disseminating cutting-edge findings. Early volumes documented pivotal research into the renin-angiotensin system, the role of the kidney in blood pressure regulation, and the epidemiology of cardiovascular disease.
The journal's scope encompasses a broad spectrum of hypertension-related research, from molecular mechanisms and genetics to large-scale clinical trials and public health interventions. It regularly features original investigations on topics such as endothelial dysfunction, vascular remodeling, obesity, salt sensitivity, and novel antihypertensive therapies. Published by the American Heart Association under its Lippincott Williams & Wilkins imprint, the journal operates on a monthly publication schedule. It utilizes a hybrid open-access model, allowing authors to choose between traditional subscription-based or open-access publication routes to meet funder mandates from organizations like the National Institutes of Health or the Wellcome Trust.
*Hypertension* is extensively abstracted and indexed in all major scientific databases, ensuring wide discoverability and citation. Key services that include the journal are the Science Citation Index Expanded, Scopus, PubMed, and MEDLINE. Its inclusion in the Journal Citation Reports by Clarivate Analytics provides its annual impact factor, a key metric of its influence. The journal is also indexed in specialized resources like Embase, Chemical Abstracts Service, and Current Contents, making its content accessible to researchers in fields ranging from clinical medicine to pharmacology and biochemistry.
The journal maintains a consistently high impact factor, reflecting its role as one of the most authoritative sources in its field. Published research from *Hypertension* frequently informs clinical practice guidelines issued by bodies such as the American College of Cardiology and the European Society of Cardiology. Its articles are regularly cited in major medical textbooks and are featured in news coverage by outlets like Reuters Health and Medscape. The journal's annual awards, including the prestigious Hypertension Research Award, recognize outstanding contributions and further cement its standing within the global scientific community.
The journal is overseen by an international editorial board composed of leading experts from institutions worldwide, such as the University of Glasgow, Harvard Medical School, and the University of Michigan. The editor-in-chief, Professor Anna F. Dominiczak, guides the journal's scientific direction and editorial policy. The board's rigorous peer-review process involves specialists from diverse disciplines including nephrology, pharmacology, and epidemiology. Governance and strategic oversight are provided by the American Heart Association's Scientific Publishing Committee, ensuring alignment with the broader mission of the organization to combat cardiovascular disease.
Category:American Heart Association Category:Hypertension journals Category:Monthly journals Category:English-language journals Category:Publications established in 1979